What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?
Xiong L, Nguyen JK, Peng Y, Zhou Z, Ning K, Jia N, Nie J, Wen D, Wu Z, Roversi G, Palacios DA, Abramczyk E, Munoz-Lopez C, Campbell JA, Cao Y, Li W, Zhang X, He Z, Li X, Huang J, Shou J, Wu J, Chen M, Chen X, Zheng J, Xu C, Zhong W, Li Z, Dong W, Zhao J, Zhang H, Luo J, Liu J, Sun F, Han H, Guo S, Dong P, Zhou F, Yu C, Campbell SC, Zhang Z.
Eur Urol. 2022 May;81(5):492-500. doi: 10.1016/j.eururo.2021.12.036. Epub 2022 Jan 19.
PMID:35058086
Emphysematous pyelonephritis.
Koratala A, Malpartida FR, Zeng X.
Clin Case Rep. 2018 Jan 4;6(2):439-441. doi: 10.1002/ccr3.1364. eCollection 2018 Feb.
PMID:29445494
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.
Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK.
J Am Soc Nephrol. 2015 Aug;26(8):1765-76. doi: 10.1681/ASN.2015010006. Epub 2015 Mar 25.
PMID:25810494
Dapagliflozin-entresto protected kidney from renal hypertension via downregulating cell-stress signaling and upregulating SIRT1/PGC-1alpha/Mfn2-medicated mitochondrial homeostasis.
Ko SF, Yang CC, Sung PH, Cheng BC, Shao PL, Chen YL, Yip HK.
Exp Biol Med (Maywood). 2023 Dec;248(23):2421-2439. doi: 10.1177/15353702231198087. Epub 2023 Dec 7.
PMID:38059322
Antioxidant Properties of Alpha-Lipoic (Thioctic) Acid Treatment on Renal and Heart Parenchyma in a Rat Model of Hypertension.
Martinelli I, Tomassoni D, Roy P, Di Cesare Mannelli L, Amenta F, Tayebati SK.
Antioxidants (Basel). 2021 Jun 23;10(7):1006. doi: 10.3390/antiox10071006.